-
Drug-Sensitized Yeast for mTOR Inhibitor Discovery
2026-08-12
Breen and colleagues developed a genetically drug-sensitized Saccharomyces cerevisiae platform that substantially improves detection of TOR/mTOR pathway inhibitors. The system distinguished known inhibitors, identified aminophylline as a TOR1-dependent growth inhibitor, and found no detectable TOR inhibition for Canagliflozin under the tested yeast conditions.
-
SmD2 Acetylation Links Splicing to PARP Sensitivity
2026-08-12
This study identifies acetylation-dependent control of the core spliceosome protein SmD2 as a determinant of alternative splicing, DNA-repair capacity, and PARP inhibitor response in hepatocellular carcinoma. Its mechanistic model supports combining HDAC2-directed epigenetic modulation with olaparib to expose a therapeutic vulnerability in HCC models.
-
Ciprofloxacin–Tetracycline Antagonism at Single-Cell Scale
2026-08-11
A recent Molecular Systems Biology study uses microfluidics to show that ciprofloxacin–tetracycline antagonism is driven primarily by improved survival under combination treatment, rather than by a simple population-level growth effect. Single-cell SOS measurements further reveal low- and high-SOS death-prone subpopulations whose relative abundance changes with nutrient conditions.
-
3X (DYKDDDDK) Peptide for FLAG Workflows
2026-08-11
The 3X (DYKDDDDK) Peptide supports sensitive FLAG fusion-protein detection, competitive elution, and structural-biology workflows without adding a large domain to the construct. Its value is greatest when tandem-epitope accessibility, metal compatibility, and orthogonal controls are built into the experimental design.
-
Gly-Gly-Phe-Gly: Practical Linker Workflows
2026-08-10
Gly-Gly-Phe-Gly (GGFG) is a flexible peptide spacer for controlled drug conjugation, antibody engineering, and biomaterial construction. This guide translates linker design into executable workflows, analytical controls, and troubleshooting decisions while clearly separating product-enabled recommendations from findings in oncology pharmacology.
-
GW 4869: Exosome Workflow for Osteogenesis
2026-08-09
Use GW 4869 as a mechanistic exosome release inhibitor to separate vesicle-dependent signaling from soluble effects in lithium-engineered BMSC models. This workflow connects neutral sphingomyelinase activity, ceramide biology, exosomal Wnt10a, and β-catenin-driven bone formation while emphasizing controls that prevent overinterpreting particle-count changes.
-
D-N-Acetylgalactosamine: Protocol and QC Guide
2026-08-08
D-N-Acetylgalactosamine provides a defined, high-purity amino sugar for aqueous or DMSO-based workflows examining glycoprotein composition, brain heteropolysaccharides, and related glycosylation pathways. It should not be selected for ethanol-based protocols or workflows requiring long-term storage of prepared solutions.
-
PTCH1-Driven NPC Differentiation for Spinal Cord Repair
2026-08-07
The reference study identifies ion-composition-optimized layered double hydroxides as active regulators of neural progenitor cell differentiation rather than merely passive delivery materials. Its results connect the stronger activity of MgAl-LDH to PTCH1-associated signaling and show that implantation of MgAl-LDH-pretreated progenitor cells improves functional outcomes in a spinal cord injury model.
-
HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody: Technic
2026-08-07
The HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive fluorescent detection of rabbit primary antibodies, specifically in immunofluorescence, microscopy, and flow cytometry workflows. It is not suitable for direct detection of non-rabbit targets or for assays requiring direct labeling of non-IgG antigens. Careful protocol alignment and handling are required to ensure signal fidelity and reproducibility.
-
Cholesterol Impairs Intracellular Trafficking of Lipid Nanop
2026-08-06
This study demonstrates that elevated cholesterol content within lipid nanoparticles (LNPs) hinders their intracellular trafficking, resulting in reduced delivery efficiency of nucleic acid cargo. The findings clarify the mechanistic role of cholesterol in endosomal aggregation and highlight critical formulation considerations for LNP-based RNA delivery systems.
-
Pam3CSK4 TFA: Synthetic TLR1/2 Agonist for Innate Immunity R
2026-08-06
Pam3CSK4 TFA is a potent synthetic TLR1/2 agonist critical for dissecting innate immune responses. Its high purity and reproducible activity support advanced cytokine profiling in both in vitro and in vivo studies. This article details its mechanism, application boundaries, and evidence benchmarks.
-
hiPSC-Derived Intestinal Organoids Advance CYP2C19 PK Modeli
2026-08-05
Takumi Saito et al. (2025) introduce a direct, efficient protocol for generating human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) with mature enterocyte features and functional CYP enzyme activity. This model enables robust, physiologically relevant pharmacokinetic studies of orally administered drugs, addressing key limitations of animal and cancer cell line systems.
-
GRE Combination Suppresses Melanogenesis via CREB/MITF Modul
2026-08-05
The study demonstrates that a combination of glabridin, resveratrol, and ellagic acid (GRE) robustly inhibits melanin production, oxidative stress, and inflammation in cell models by downregulating the CREB/MITF pathway. These findings highlight GRE’s promise as a mechanistically defined, multi-target approach for pigmentation regulation and potential therapy of hyperpigmentation disorders.
-
2,2,2-Trichloroethanol: Precision Biochemical for Dopaminerg
2026-08-04
Explore the advanced utility of 2,2,2-Trichloroethanol as a small molecule biochemical in dopaminergic neuron research and protein analysis. This article uniquely connects assay design with neuroimaging breakthroughs, offering practical guidance for translational neuroscience.
-
7ACC2: Redefining Cancer Metabolism Research Through Dual MC
2026-08-04
Explore how 7ACC2, a potent monocarboxylate transporter 1 inhibitor, is revolutionizing cancer metabolism research with its unique dual mechanism. This article delves deeper than standard reviews, integrating the latest immunometabolic findings and practical assay guidance.